Abstract
Neisseria meningitidis serogroup W-135 appears to be a fairly common cause of infection associated with properdin deficiency or dysfunction, and anticapsular antibodies might be protective in these patients. For this reason, bactericidal and opsonophagocytic activities for serogroup W-135 were investigated before and four weeks after vaccination of two properdin-deficient adults with tetravalent meningococcal vaccine. In addition, the response of IgM, IgG and IgA class antibodies to the serogroups A, C, Y and W-135 was determined by ELISA. There was no evidence of poor antibody responses in the properdin-deficient persons. Vaccination promoted classical pathway-mediated killing in serum and opsonization of serogroup W-135 to the same extent as that seen in vaccinated controls. The increase of alternative pathway-mediated killing in the properdin-deficient sera was moderate, but vaccination clearly enhanced alternative pathway-mediated opsonophagocytosis in the sera. It was also shown that vaccination markedly reduced the requirement for properdin in alternative pathway-mediated killing of the meningococci.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goldschneider, I., Gotschlich, E. C., Artenstein, M. S. Human immunity to the meningococcus. I: The role of humoral antibodies. Journal of Experimental Medicine 1969, 129: 1307–1326.
Ross, S. C., Densen, P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 1984, 63: 243–272.
Sjöholm, A. G., Braconier, J. H., Söderström, C. Properdin deficiency in a family with fulminant meningococcal infections. Clinical and Experimental Immunology 1982, 50: 291–297.
Densen, P., Weiler, J. M., Griffiss, J. M., Hoffmann, L. G. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. New England Journal of Medicine 1987, 316: 922–926.
Nielsen, H. E., Koch, C. Congenital properdin deficiency and meningococcal infection. Clinical Immunology and Immunpathology 1987, 44: 134–139.
Späth, P. J., Misiano, G., Schaad, U. B., Rohner, R., Scherz, R., Uring-Lambert, B., Hauptmann, G., Butner, G.: Association of heterozygous C4A and complete factor P deficient conditions. Complement 1985, 2: 74A.
Sjöholm, A. G., Kuijper, E. J., Tijssen, C. C., Jansz, A., Bol, O., Spanjaard, L., Zanen, H. C. Dysfunctional properdin in a Dutch family with meningococcal disease. New England Journal of Medicine 1988, 319: 33–37.
Sjöholm, A. G. Absence and dysfunction of properdin as a basis for susceptibility to meningococcal disease. Immunopathology and Immunotherapy Forum 1989, 4: 8–11.
Fearon, D. T., Austen, K. F. The alternative pathway of complement. A system for host resistance to microbial infection. New England Journal of Medicine 1980, 303: 259–263.
Pangburn, M. K., Müller-Eberhard, H. J. The alternative pathway of complement. Springer Seminars in Immunopathology 1984, 7: 163–192.
Sissons, J. G. P., Schreiber, R. D., Perrin, L. H., Cooper, N. R., Müller-Eberhard, H. J., Oldstone, M. B. A. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody. Journal of Experimental Medicine 1979, 150: 445–454.
Schifferli, J. A., Steiger, G., Hauptmann, G., Späth, P. J., Sjöholm, A. G. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization. Journal of Clinical Investigations 1985, 76: 2127–2133.
Söderström, C., Braconier, J. H., Danielsson, D., Sjöholm, A. G. Bactericidal activity forNeisseria meningitidis in properdin-deficient sera. Journal of Infectious Diseases 1987, 156: 107–112.
Forsgren, A., Quie, P. G. Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology 1974, 26: 1251–1256.
Käyhty, H., Eskola, J., Peltola, H., Stout, M. G., Samuelson, J. S., Gordon, L. K. Immunogenicity in infants of a vaccine composed ofHaemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. Journal of Infectious Diseases 1987, 155: 100–106.
Watt, P. J. The fate of gonococci in polymorphonuclear leucocytes. Journal of Medical Microbiology 1970, 3: 501–509.
Siegal, S. Nonparametric statistics for the behavioral sciences. McGraw Hill, New York, 1956, p. 75–83.
Braconier, J. H., Sjöholm, A. G., Söderström, C. Fulminant meningococcal infections in a family with inherited deficiency of properdin. Scandinavian Journal of Infectious Diseases 1983, 15: 339–345.
Herva, E., Leinonen, M., Käyhty, H., Mäkelä, H., Vetoniemi-Korhonen, S.-L. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response. Journal of Infection 1983, 6: 55–60.
Böttger, E. C., Hoffmann, T., Hadding, U., Bitter-Suerman, D. Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. Journal of Immunology 1985, 135: 4100–4107.
Sjöholm, A. G., Söderström, C., Nilsson, L.-Å. A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males. Complement 1988, 5: 130–140.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Söderström, C., Braconier, J.H., Käyhty, H. et al. Immune response to tetravalent meningococcal vaccine: Opsonic and bactericidal functions of normal and properdin deficient sera. Eur. J. Clin. Microbiol. Infect. Dis. 8, 220–224 (1989). https://doi.org/10.1007/BF01965264
Issue Date:
DOI: https://doi.org/10.1007/BF01965264